2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management

In: International Journal of Gynecological Cancer · 2022 · vol. 32 , pp. A221–A222 · doi:10.1136/ijgc-2022-esgo.480 · W4312595723
article OA: bronze CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-29 ⓘ

This paper analyzes the clinical characteristics, prognosis, and management of endometrioid borderline ovarian tumors based on data from the 2022-RA-173-ESGO study.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK